Tesla reported Q3 2026 earnings per share of US$0.24 and net income of US$787m, with revenue roughly flat year over year at US$28,046m. Net income fell 42.7% from US$1,373m a year earlier, and the trailing 12-month net margin compressed to 3.1% from 5.3%. Services and other margins hit a record 15.9%, and FSD has over 1.7 million paying users with a North American attach rate above 75%. Optimistic investors expect AI and robotics to become recurring high-margin revenue, while cautious investors warn that capex above US$25b a year could strain free cash flow and delay returns. Shares slipped about 0.6% in the latest session.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
TSLAearningselectric vehiclesartificial intelligence
Open a keyword to see other news on the same topic.
Related tickers and likely impact
TSLA
▼ Likely negativeTesla, Inc.
Relevance: high
| Market | US stocks |
|---|---|
| Sector | Consumer Discretionary |
| Industry | Automobile Manufacturers |
| Market cap | $1.4T |
| Close on 10/23/2026 | 372.21 |
| Change that session | -0.63% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- TSLA Q3 deep dive: autonomy adoption and margin dynamics shape outlook
Tesla (TSLA) reported Q3 2026 revenue of $28.05 billion, in line with analyst expectations but flat year on year. Non-GAAP EPS of $0.48 beat consensus by 6.3%. Gross margin rose to 19.6% from 18%, while operating margin fell to 2.6% from 5.8%, and market capitalization stood at $1.53 trillion. Management attributed demand to growing FSD adoption, with over 75% of North American deliveries including a paid FSD sign-up, and to the highest vehicle backlog in four years. Operating expenses are expected to keep rising until Optimus, Megapack 3 and the Semi reach commercialization.
- Tesla Reports A Great 3rd Quarter , Robotaxi & FSD Finally Taking Off
Tesla's third-quarter revenue was roughly flat at $28.05 billion, while gross margin rose from 16.8% to 19.6% and operating margin nearly doubled to 2.6%. The company posted surprise positive free cash flow of $1.53 billion on capex of $4.73 billion, and cut its full-year capex guidance to about $20 billion from more than $25 billion. Active FSD subscriptions rose to 1.74 million from 1.48 million, and unsupervised Robotaxi miles reached 3.3 million, while management said battery availability rather than demand was the limiter on vehicle volumes and set a goal of 5 million vehicles a year by 2030. Tesla hopes to roll out unsupervised FSD to customer-owned vehicles in Q2 next year, but the author notes that this target has slipped many times and the feature is geofenced for now.
- Where is Optimus? Key questions for Tesla earnings.
Hosts of The 8:30 preview Tesla's (TSLA) earnings report, where investors want updates on the Optimus robot, robotaxi expansion beyond Austin and SF, and capital expenditure. The key figures cited are revenue of $28.13 billion and EPS of 44 cents. Tesla announced capex of about $25 billion last quarter, and the hosts question whether it will go higher. The stock rose only about 1.7% this morning despite news of a possible SpaceX merger, and is still down 17% year to date after a strong rebound from its lows.
- Did Tesla's Fall Catch You Out? What Investors Missed
Tesla shares fell 20.7% over the past year, including dividends, despite the company's focus on robotaxis, humanoid robots and AI chip plans. Revenue rose to US$28.24b in Q2 2026 from US$22.50b a year earlier, but net income slipped to US$1.12b and net margin fell from 5.2% to 4.0%, challenging the assumption that heavy AI and robotics spending would quickly lift profitability. The article compares two narratives: one with a Fair Value of US$500, and a more cautious one at US$332 that treats slower product ramps and tariff-driven cost pressure as risks. Tesla now trades at US$355, after starting the period at US$429. The piece asks whether Tesla can turn Optimus and robotaxi economics into recurring revenue.
- Tesla Got Trump Tariff Refunds, and Elon Musk Isn’t Sitting on the Cash — CFO Says Money Is Going Into...
Tesla is reinvesting recent tariff refunds into expanding U.S. manufacturing capacity, CFO Vaibhav Taneja said on the third-quarter earnings call. Energy gross margin improved sequentially from 20.4% to 33.1%, primarily due to tariff refunds recognized in the quarter and warranty true-downs tied to cell-related costs. Capital expenditures are expected to keep rising over the next few years to add Robotaxi fleet, expand Optimus production, install solar manufacturing, purchase AI compute infrastructure and build a semiconductor fab. CEO Elon Musk targets 5 million vehicles a year by around 2030, while the Austin-based Terafab research fab is expected to begin commissioning machinery in the first half of next year. TSLA was 5.32% lower in premarket trading Thursday after closing up 3.41% at $386.47 Wednesday, and is up 14.06% year-to-date.
- Stocktwits Zero To Sixty: Tesla And SpaceX Form Merger Committees As Profits Drop, While Rivian Buys AI Startup And GM, Ford Advance EV Plans
Elon Musk publicly endorsed a possible merger of Tesla and SpaceX, and both companies have formed special committees of independent directors to evaluate it, while Musk has recused himself from the talks due to conflicts of interest and discussions remain at an early stage. In the third quarter, Tesla reported revenue of $28 billion (below the $28.3 billion estimate) and adjusted EPS of $0.48 per share (above the expected $0.45), but both revenue and earnings declined from the same period in 2025. Capital expenditure rose 110% to $4.7 billion, while the full-year capex estimate was cut to $20 billion from $25 billion, and Tesla aims to begin delivering Cybercabs to external fleet customers by the end of 2026. Rivian acquired UK-based Third Dimension AI to support its driver-assistance and robotaxi software, while GM unveiled a fourth-generation EV platform using lithium manganese-rich prismatic cells with about 33% more energy density than lithium iron phosphate.
Related markets
Latest news
- Why McDonalds, Microsoft and Google saying no to tokenized stocks isn't a dealbreaker
So far 22 publicly traded companies have objected to having their shares tokenized and traded on the OKX and ICE venue under the SEC's innovation exemption, including Microsoft, Alphabet, Goldman Sachs, McDonalds, Wells Fargo and Cisco. Under the rules, a venue must notify the issuer and allow 30 days to object; silence counts as consent and cannot be withdrawn once trading begins, so objecting can be the rational choice for legal and investor-relations teams still assessing the new structure. Some industry figures say the objections reflect caution toward a new process rather than rejection of tokenization, while Nasdaq objects to trading tokenized versions of its stock outside the National Market System over concerns about fragmented liquidity and weaker price discovery. Securitize and BitGo said they will not object to the listing.
- Americans Are Gloomier Than at Almost Any Time on Record, Michigan Survey Shows
The University of Michigan's final October consumer sentiment index came in at 48.0, revised up from 46.3, almost level with September and a five-month low. The current-conditions index fell to 46.7, with buying conditions for durables such as cars and appliances down 18% amid higher interest rates and affordability concerns. Year-ahead and long-run inflation expectations rose to 4.7% and 3.5%, both the highest since May, while the Federal Reserve raised rates by 25 basis points in September to 3.75%–4.00% and meets again on October 28. Retail sales reached $745.0 billion in September, up 0.8% from August, suggesting shoppers are still spending despite weaker sentiment. The SPDR S&P Retail ETF (XRT) gained 6.76% over the past month, while SPY slipped 0.52% on the release day; because XRT weights its holdings roughly equally, smaller auto dealers and specialty stores carry as much weight as larger names if durables demand keeps weakening.
- Argentina drops criminal probe into President Milei over crashed memecoin LIBRA
An Argentine federal judge dismissed the criminal case against President Javier Milei over his promotion of the memecoin LIBRA, ruling that his endorsement and the token's later collapse did not establish fraud without evidence of a specific deception. Eleven people were cleared, including Milei's sister Karina and U.S. businessman Hayden Davis, though none had been formally questioned. LIBRA lost more than 95% of its value after reaching about $5, while eight wallets linked to its creator withdrew around $99 million in crypto. The presidency called the probe an attempt to harm Milei's reputation, and the prosecutor is not expected to appeal. Investors who were removed as plaintiffs are challenging that decision, and if reinstated they could appeal the dismissal.
- Vanguard Morningstar Growth ETF vs. Vanguard Information Technology ETF: Here's Which One I Believe Is the Clear Long-Term Winner.
The article compares two Vanguard ETFs: the Vanguard Morningstar Growth ETF (VUG), which holds 135 large-cap growth stocks at a 0.03% expense ratio, and the Vanguard Information Technology ETF (VGT), which holds 318 U.S. tech stocks at 0.09%. Over the past decade, VGT returned 775% versus 420% for VUG, and a hypothetical $10,000 investment in VGT would be worth almost $88,000. Both funds have benefited from the AI boom, but VGT is more concentrated in Nvidia, Apple and Microsoft and has a 38% semiconductor weighting, while VUG offers more sector diversification. The author, who has 30 years until retirement, chooses VGT for its long-term potential, and says investors seeking less aggressive exposure could allocate 5% to 10% of their portfolios to it.
- Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
A late-stage trial found that adding Amgen's Imdelltra to AstraZeneca's Imfinzi cut the risk of death by 58% in patients with extensive-stage small cell lung cancer. Median overall survival rose to 21.1 months, compared with 12.7 months for Imfinzi alone, in patients whose cancer had not progressed after initial Imfinzi and chemotherapy. Nearly 80% of patients on the combination were alive at one year, versus 53% on Imfinzi alone. Imdelltra posted $288 million in second-quarter sales, up 115% year over year, after $627 million in global sales in 2025. Amgen said the results suggest earlier use of the drug could meaningfully alter the course of the disease, though the trial did not compare the combination with other first-line treatments.
- AMC Stock: You Can See Everything
AMC Entertainment's stock is up 86% in 2026 as domestic box office receipts rise 21% from a year earlier, helped by A24's documentary You Can See Everything. The film took in $15.7 million in ticket sales over its opening weekend from just 855 screens, the strongest opening for a non-musical documentary in more than 20 years, and is expanding to more than 2,500 screens. Analysts expect AMC's revenue to rise 18% to $5.7 billion, and the chain could post positive adjusted earnings for the first time since 2018. The author says the business has improved on fundamentals such as concessions and its loyalty program, but notes the stock is still down 99.2% over the past year. The author is willing to take the risk on the shares, arguing the current rally reflects improving fundamentals rather than hype.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.